Glass-contaminated capsules lead to pharmaceutical recall

12-26-2012
Off
0

Atorvastatin, a generic form of the drug Lipitor, has been recalled due to dangers that some of the capsules may be contaminated with glass particles. However, the recall has only been issued to pharmacies, instructing them not to distribute contaminated lots, with no word given to patients who may already have the drug at home.

According to the FDA, patients can safely continue taking the prescriptions already in their possession, and one major pharmacy has even gone so far as to refuse to exchange the recalled atorvastatin for another brand. However, Consumer Reports recommends that those affected err on the side of safety by returning the medicine to their pharmacist and requesting a different brand.

The FDA has in the past accused Ranbaxy, the India-based pharmaceutical company behind the recalled drug, of “systemic fraudulent conduct,” including poor quality standards. Between 3 and 4 million people take Ranbaxy’s atorvastatin.

Have you suffered a serious medical problem due to a contaminated drug? You may have a product liability case. Contact Hodes Milman Liebeck lawyers online at www.hmlm.com today.

Contact Us Today for Your

FREE CONSULTATION

Fill out the form below and we'll be in touch within 24 hours!